Narrative review / 2016
Short sleep duration and sleep disorders are related to adverse cardiometabolic risks such as obesity, hypertension, type 2 diabetes, and cardiovascular disease.
This American Heart Association scientific statement reviews evidence linking sleep duration and sleep disorders to cardiometabolic health. It notes a decline in average sleep duration among Americans due to curtailing sleep for work, social, or leisure activities. Sleep duration, particularly short sleep, and sleep disorders have emerged as related to adverse cardiometabolic risks, including obesity, hypertension, type 2 diabetes mellitus, and cardiovascular disease. The authors call for health organizations to incorporate evidence-based sleep recommendations into guidelines for optimal health.
Shows an association, not proof of cause and effect.
- Study type
- Scientific statement / narrative review
- Who was studied
- Americans / general human populations
- What was measured
- Cardiometabolic risk, including obesity, hypertension, type 2 diabetes, and CVD
THE PAPER
Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association.
St-Onge MP, Grandner MA, Brown D, Conroy MB, Jean-Louis G, Coons M, Bhatt DL, American Heart Association Obesity, Behavior Change, Diabetes, and Nutrition Committees of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. Circulation, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.